Poultry Vaccines Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 3.47 billion by 2030 and is anticipated to register a CAGR of 5.8%. Vaccination is an important aspect of the chicken flock's health management. Vaccinating birds against a variety of diseases prevents the spread of disease. A vaccine helps to avoid a disease by inducing or enhancing the production of antibodies in the bird's immune system, which then fight the invading causative organisms. Chicken vaccines play a crucial part in keeping poultry flocks healthy. Vaccinating the chicken flock helps to prevent a variety of diseases. Vaccines create antibodies that aid the body of the bird in fighting off invading pathogens.
The report " Global Poultry Vaccines Market, By Type (Live Vaccines and Killed Vaccines), By Application (Chicken and Duck & Goose), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029’’
Key Highlights:
· In May 2021, Boehringer Ingelheim India today announced the launch of its poultry vaccine VAXXITEK HVT IBD. An innovative recombinant vaccine, VAXXITEK HVT IBD is a single shot vaccine, ensuring life-long protection for all types of production chickens, namely broiler, layer and breeder.
· In April 2021, Boehringer Ingelheim has announced the launch of a new set of Marek's disease vaccines in the UK and the EU, named PREVEXXION RN and PREVEXXION RN HVT IBD.
Analyst View:
The global market is being driven by an increase in the frequency of zoonotic illnesses in poultry and an increase in the number of poultry. In addition, rising meat consumption around the world and rising demand for poultry-related food products are driving the global poultry vaccines market forward. Over the forecast period, advancements in vaccination technology and government initiatives are expected to propel the global poultry vaccines market forward.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/1566
Key Market Insights from the report:
The Global Poultry Vaccine Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 3.47 billion by 2030 and is anticipated to register a CAGR of 5.8%. The Global Poultry Vaccine Market is segmented based on the type, application and region.
· By Type, the market is segmented into Live Vaccines and Killed Vaccines.
· By Application, the market is segmented into Chicken and Duck & Goose.
· By Region, the Global Poultry Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate over the Forecast Period.
Competitive Landscape:
The key players operating in the global Poultry Vaccine market includes Boehringer Ingelheim GmbH, Elanco Animal Health Incorporate, Merck and Co., Inc., Zoetis, Inc., Ceva Animal Health, Inc., Phibro, Animal Health Corporation, Venkys Ltd., Intervac Pvt Ltd, Anicon GmbH and ASP, Inc.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
